Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,022 | -6,935 | -21,123 | -15,630 | -9,844 |
| Depreciation Amortization | 30 | 15 | 70 | 56 | 40 |
| Accounts payable and accrued liabilities | 342 | -32 | 424 | 490 | 307 |
| Other Working Capital | -72 | -250 | 135 | -104 | -394 |
| Other Operating Activity | 466 | 431 | 1,366 | 987 | 737 |
| Operating Cash Flow | $-12,256 | $-6,771 | $-19,128 | $-14,201 | $-9,154 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 7,174 | 7,174 | 7,174 |
| PPE Investments | -4 | -2 | -5 | -2 | -2 |
| Investing Cash Flow | $-4 | $-2 | $7,169 | $7,172 | $7,172 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 532 | 18,519 | 17,401 | 17,400 |
| Other Financing Activity | 3,462 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,462 | $532 | $18,519 | $17,401 | $17,400 |
| Exchange Rate Effect | -19 | -2 | -5 | -3 | -4 |
| Beginning Cash Position | 25,585 | 25,585 | 19,030 | 19,030 | 19,030 |
| End Cash Position | 16,768 | 19,342 | 25,585 | 29,399 | 34,444 |
| Net Cash Flow | $-8,817 | $-6,243 | $6,555 | $10,369 | $15,414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,256 | -6,771 | -19,128 | -14,201 | -9,154 |
| Capital Expenditure | -4 | -2 | -5 | -2 | -2 |
| Free Cash Flow | -12,260 | -6,773 | -19,133 | -14,203 | -9,156 |